Inventor · disambiguated record
Kar Muthumani
Also filed as: MUTHUMANI KAR
11 granted patents·26 pending applications·7 citations·filing 2017–2024
82Inventor score
Top patents by PatentIndex Score
37 records- 0193US11660335B2Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2021·Granted May 30, 2023·2 cites·21 claims
- 0286US11896654B2DNA monoclonal antibodies targeting checkpoint moleculesUNIV PENNSYLVANIA·Filed 2017·Granted Feb 13, 2024·3 cites·16 claims
- 0383US2025121054A1Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0481US11230592B2DNA antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2018·Granted Jan 25, 2022·2 cites·8 claims
- 0576US12419945B2Vaccines against Zika virusUNIV PENNSYLVANIA·Filed 2023·Granted Sep 23, 2025·0 cites·17 claims
- 0676US2023338515A1Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0776US2024376179A1Dna antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2024·Application pending·0 cites
- 0874US2024189405A1DNA Monoclonal Antibodies Targeting Checkpoint MoleculesUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0972US11981724B2DNA antibody constructs for use against middle east respiratory syndrome coronavirusWISTAR INST·Filed 2021·Granted May 14, 2024·0 cites·14 claims
- 1063US2025236670A1Antibodies Against Human Siglec-7 and Use Thereof for ImmunotherapyWISTAR INST·Filed 2023·Application pending·0 cites
- 1163US2025215078A1Antibodies Against Human Siglec-9 and Use Thereof for ImmunotherapyWISTAR INST·Filed 2023·Application pending·0 cites
- 1263US2025223369A1Bispecific Natural Killer Engagers That Target Siglec-7WISTAR INST·Filed 2023·Application pending·0 cites
- 1362US2023159602A1Engineered optimized cytokine compositionsTHE WISTAR INST·Filed 2022·Application pending·0 cites
- 1461US11021520B2Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using the sameUNIV PENNSYLVANIA·Filed 2018·Granted Jun 1, 2021·0 cites·20 claims
- 1559US2022370598A1Vaccines Against Coronavirus and Methods of UseINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1658US2018346554A1Dna antibody constructs and method of using sameUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 1758US2024101626A1Consensus prostate antigens, nucleic acid molecules encoding the same, and vaccines and uses comprising the sameMUTHUMANI KAR·Filed 2022·Application pending·0 cites
- 1855US12357683B2Vaccines against Nipah virus, and methods of using sameWISTAR INST·Filed 2019·Granted Jul 15, 2025·0 cites·13 claims
- 1955US12296001B2DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)WISTAR INST·Filed 2019·Granted May 13, 2025·0 cites·14 claims
- 2054US2023210989A1Monoclonal Antibody Against Human Siglec-9 and Use For ImmunotherapyMUTHUMANI KAR·Filed 2021·Application pending·0 cites
- 2154US2023212267A1Dna antibody constructs for use against sars-cov-2WEINER DAVID·Filed 2021·Application pending·0 cites
- 2253US2023256074A1Vaccines against african swine fever virus, and methods of using sameWISTAR INST·Filed 2020·Application pending·0 cites
- 2353US2023203133A1Dna antibody constructs for use against hepatitis b virusWISTAR INST·Filed 2021·Application pending·0 cites
- 2453US2024016919A1INTRADERMAL MERS-CoV VACCINEWISTAR INST·Filed 2021·Application pending·0 cites
- 2553US2025249088A1THERAPEUTIC AND VACCINE CANDIDATES AGAINST SARS-CoV-2GENEONE LIFE SCIENCE INC·Filed 2022·Application pending·0 cites
- 2651US11648303B2Vaccines against zika virusUNIV PENNSYLVANIA·Filed 2017·Granted May 16, 2023·0 cites·17 claims
- 2750US12194086B2Mayaro virus consensus antigens, DNA antibody constructs for use against Mayaro virus, and combinations thereofWISTAR INST·Filed 2018·Granted Jan 14, 2025·0 cites·11 claims
- 2850US2021101952A1Engineered Optimized Cytokine CompositionsTHE WISTAR INST·Filed 2019·Application pending·0 cites
- 2949US2022381787A1Novel lox-1 antibody compositions, lox1 neutralization assay and methods of treatment using sameWISTAR INST·Filed 2020·Application pending·0 cites
- 3049US2019055294A1Compositions Comprising Hypoxia Inducible Factor-1 Alpha and Methods of Using the SameUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 3148US12110342B2Nucleic acid monoclonal antibodies targeting PCSK9 and methods of useWISTAR INST·Filed 2019·Granted Oct 8, 2024·0 cites·14 claims
- 3248US2020147195A1Dtert vaccines and methods of treatment using the sameWISTAR INST·Filed 2018·Application pending·0 cites
- 3347US2024207385A1Compositions comprising self-assembling vaccines and methods of using the sameWISTAR INST·Filed 2021·Application pending·0 cites
- 3446US2021047390A1Nucleic acid antibody constructs for use against respiratory syncytial virusWISTAR INST·Filed 2019·Application pending·0 cites
- 3546US2019275138A1Foot and mouth disease virus serotype o (fmdv-o) vaccineWISTAR INST·Filed 2017·Application pending·0 cites
- 3645US2022098324A1Dna-encoded bispecific t-cell engagers targeting cancer antigens and methods of use in cancer theraputicsWISTAR INST·Filed 2020·Application pending·0 cites
- 3735US2021153484A1Humanized Mouse ModelThe Wistar lnstitute·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kar Muthumani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →